Genetic Technologies Limited
Genetic Technologies Limited (GNTLF) Revenue
Annual & quarterly revenue history · segment & region breakdown
GNTLF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsGenetic Technologies Limited trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Medical - Diagnostics & ResearchCompare GNTLF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Genetic Technologies Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Genetic Technologies Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Genetic Technologies Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GNTLF revenue · 4 questionsGNTLF's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Genetic Technologies Limited SEC filings · GAAP · Genetic Technologies Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026